Frequent varicella zoster reactivation associated with therapeutic use of arsenic trioxide: Portents of an old scourge

被引：23

作者：

Au, WY ^{[1
]}

Kwong, YL ^{[1
]}

机构：

[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 53卷 / 05期

关键词：

D O I：

10.1016/j.jaad.2005.07.030

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

In 44 patients treated with arsenic trioxide (As2O3) for acute promyelocytic leukemia, 11 developed varicella zoster virus (VZV) reactivation (median 56 days [range 15-2991) after treatment. There was no preferential dermatome involvement or systemic spread. The actuarial risk of VZV reactivation at 1 year was 26%. No VZV reactivation occurred after the first year of initial treatment with AS(2)O(3).

引用

页码：890 / 892

页数：3

共 11 条

[1] Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia [J].

Au, WY ;

Kumana, CR ;

Kou, M ;

Mak, R ;

Chan, GCF ;

Lam, CW ;

Kwong, YL .

BLOOD, 2003, 102 (01) :407-408

[2] Acute arsenic poisoning:: clinical and histopathological features [J].

Bartolomé, B ;

Córdoba, S ;

Nieto, S ;

Fernández-Herrera, J ;

García-Díez, A .

BRITISH JOURNAL OF DERMATOLOGY, 1999, 141 (06) :1106-1109

[3]

Kwong Yok-Lam, 2004, Expert Opin Drug Saf, V3, P589, DOI 10.1517/14740338.3.6.589

[4]

Leung AYH, 2002, HAEMATOLOGICA, V87, P444

[5]

Omura GA, 2001, ARCH DERMATOL, V137, P823

[6] THE ARSENIC-POISONING EPIDEMIC OF 1900 - ITS RELATION TO LUNG CANCER IN 1960 - AN EXERCISE IN RETROSPECTIVE EPIDEMIOLOGY [J].

SATTERLEE, HS .

NEW ENGLAND JOURNAL OF MEDICINE, 1960, 263 (14) :676-684

[7] Herpes zoster during treatment with arsenic trioxide [J].

Tanvetyanon, T ;

Nand, S .

ANNALS OF HEMATOLOGY, 2004, 83 (03) :198-200

[8] FAMCICLOVIR FOR THE TREATMENT OF ACUTE HERPES-ZOSTER - EFFECTS ON ACUTE DISEASE AND POSTHERPETIC NEURALGIA - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

TYRING, S ;

BARBARASH, RA ;

NAHLIK, JE ;

CUNNINGHAM, A ;

MARLEY, J ;

HENG, M ;

JONES, T ;

REA, T ;

BOON, R ;

SALTZMAN, R ;

BRUCE, S ;

HARRIS, A ;

EPSTEIN, A ;

LOWRY, L ;

RUBIN, H ;

DUPUY, J ;

HENDRICKS, J ;

GREER, J ;

RAPAPORT, M ;

MILLER, DJ ;

FRIEDMANN, BS ;

SILVERBROOK, RM ;

MARLEY, W ;

ZELLNER, SR ;

MICHIE, DD ;

MESTAS, F ;

KLUGE, R ;

PURVIS, QR ;

SCHLEIDER, N ;

DOMINGO, J ;

SWINEHART, JM ;

WILLIAMS, K ;

SHULTZ, L ;

ROCHAMBEAUM, B ;

CAMPBELL, D ;

PRICE, J ;

KING, M ;

MORALEDA, P ;

TORO, M ;

MORTENSEN, M ;

WALKER, M ;

STEELE, B ;

CASTELLANOS, K ;

MILLER, C ;

TERRELL, MD ;

CRANE, J ;

ZINK, R ;

SOERRIES, S ;

NESTER, C ;

NESTER, S .

ANNALS OF INTERNAL MEDICINE, 1995, 123 (02) :89-96

[9] Skin manifestations in acute arsenic poisoning from the Wakayama curry-poisoning incident [J].

Uede, K ;

Furukawa, F .

BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (04) :757-762

[10] Arsenic induces tumor necrosis factor α release and tumor necrosis factor receptor 1 signaling in T helper cell apoptosis [J].

Yu, HS ;

Liao, WT ;

Chang, KL ;

Yu, CL ;

Chen, GS .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (04) :812-819

← 1 2 →